Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors.

Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors.

Item
http://www.wikidata.org/entity/Q33215194
Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?Tumor-specific antivascular effect of TZT-1027 (Soblidotin) elucidated by magnetic resonance imaging and confocal laser scanning microscopy.Marine pharmacology in 2005-2006: antitumour and cytotoxic compounds.Colchitaxel, a coupled compound made from microtubule inhibitors colchicine and paclitaxelThe novel microtubule-interfering agent TZT-1027 enhances the anticancer effect of radiation in vitro and in vivoVascular disrupting agents in clinical developmentPredictive biomarkers in breast cancer: their value in neoadjuvant chemotherapy.Antitumor bioactive peptides isolated from marine organisms.Reference profiling of the genomic response induced by an antimicrotubule agent, TZT-1027 (Soblidotin), in vitro.Dose calculation of anticancer drugsEpothilones and new analogues of the microtubule modulators in taxane-resistant disease
P2860

Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors.

Item
http://www.wikidata.org/entity/Q33215194
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Phase I and pharmacokinetic st ...... ts with advanced solid tumors.
@ast
Phase I and pharmacokinetic st ...... ts with advanced solid tumors.
@en
type
label
Phase I and pharmacokinetic st ...... ts with advanced solid tumors.
@ast
Phase I and pharmacokinetic st ...... ts with advanced solid tumors.
@en
prefLabel
Phase I and pharmacokinetic st ...... ts with advanced solid tumors.
@ast
Phase I and pharmacokinetic st ...... ts with advanced solid tumors.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Phase I and pharmacokinetic st ...... ts with advanced solid tumors.
@en
P2093
P304
P31
P356
10.1158/1078-0432.CCR-04-1937
P407
P433
P478
P577
P698